Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 15

rPFS according with visceral or non-visceral subgroup

(PREVAIL study)

Evans C, et al. Eur Urol 2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,5,6,7,8,9,10,11,12,13,14 16,17,18,19,20,21,22,23,24,25,...42